I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 5 studies | 56% ± 13% | |
| type I pneumocyte | 5 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 5 studies | 56% ± 13% | |
| type I pneumocyte | 5 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 3 studies | 26% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1089.70 | 459 / 459 | 99% | 7.27 | 1107 / 1118 |
| prostate | 100% | 1172.01 | 244 / 245 | 98% | 3.59 | 490 / 502 |
| pancreas | 99% | 517.30 | 325 / 328 | 98% | 6.39 | 174 / 178 |
| lung | 100% | 1618.45 | 577 / 578 | 97% | 7.15 | 1120 / 1155 |
| esophagus | 100% | 608.17 | 1443 / 1445 | 96% | 6.28 | 176 / 183 |
| uterus | 99% | 772.61 | 169 / 170 | 94% | 5.28 | 433 / 459 |
| thymus | 100% | 640.84 | 651 / 653 | 88% | 2.97 | 533 / 605 |
| intestine | 92% | 512.65 | 893 / 966 | 93% | 3.10 | 491 / 527 |
| stomach | 96% | 456.50 | 343 / 359 | 87% | 2.83 | 249 / 286 |
| brain | 84% | 1255.02 | 2207 / 2642 | 97% | 3.66 | 681 / 705 |
| ovary | 91% | 377.43 | 163 / 180 | 88% | 2.82 | 377 / 430 |
| bladder | 95% | 614.57 | 20 / 21 | 82% | 3.23 | 414 / 504 |
| skin | 98% | 510.96 | 1765 / 1809 | 79% | 2.43 | 374 / 472 |
| kidney | 93% | 436.61 | 83 / 89 | 74% | 2.22 | 664 / 901 |
| adrenal gland | 74% | 282.96 | 190 / 258 | 78% | 3.62 | 180 / 230 |
| adipose | 100% | 1071.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 748.80 | 1326 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 99% | 633.15 | 239 / 241 | 0% | 0 | 0 / 0 |
| heart | 98% | 2966.56 | 845 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 3.85 | 43 / 45 |
| eye | 0% | 0 | 0 / 0 | 84% | 2.76 | 67 / 80 |
| liver | 13% | 29.44 | 29 / 226 | 53% | 2.07 | 215 / 406 |
| muscle | 16% | 43.07 | 129 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005911 | Cellular component | cell-cell junction |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0005912 | Cellular component | adherens junction |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030165 | Molecular function | PDZ domain binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MPP3 |
| Protein name | MAGUK p55 scaffold protein 3 MAGUK p55 subfamily member 3 (Discs large homolog 3) (Protein MPP3) MAGUK p55 scaffold protein 3 (Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3), isoform CRA_a) |
| Synonyms | hCG_28215 DLG3 |
| Description | FUNCTION: Participates in cell spreading through the phosphoinositide-3-kinase (PI3K) pathway by connecting CADM1 to DLG1 and the regulatory subunit of phosphoinositide-3-kinase (PI3K) . Stabilizes HTR2C at the plasma membrane and prevents its desensitization. May participates in the maintenance of adherens junctions (By similarity). . |
| Accessions | ENST00000398393.5 ENST00000398389.9 [Q13368-1] D3DX46 ENST00000496503.5 [Q13368-2] K7EPM7 Q13368 ENST00000479797.1 |
